In news late yesterday, IMS Health has filed with the US Securities and Exchange Commission (SEC) to raise up to $100 million in an initial public offering of stock. The preliminary prospectus listed JP Morgan, Goldman Sachs, Morgan Stanley and BofA Merrill Lynch as the underwriters. We have noted IMS Health’s expansiveness on entering mHealth through app curation, prescribing and data security at the mHealth Summit [TTA 23 Dec] and their previous acquisition of Diversinet [TTA 15 Aug] in mobile app security; the latter was only a small part of their 2013 acquisitions in several areas totaling $105 million. Clearly there are some plans which may very well include health apps and data. Reuters, GeekWire.